The sexual health test LDX is developing will be separate to a secondary test being developed for the hologic unit outside if FFN.
Medpro in Jan have signed or anticipate to sign 13 sales. The sales may not be directly purchased via Medpro but through out existing distributors. Sales minimum is 1 box. So that could be a minimum of $6,000 odd in revenue - hopefully a lot, lot more lol
Revenue will be slow given the admin delays in insurance process etc for the reimbursement of Febridx.
Viradx competitors are selling at 25% less than Viradx. Company works closely with partners who don't buy solely on price.
Sounds like AT1 just provides the cassettes for the BDI test and LDX does the chemical work behind it. LDX likely to have higher involvement in the studies than AT1.
Febridx study with Uni of Wollongong is going to happen at some stage soon?
- Forums
- ASX - By Stock
- LDX
- Ann: Q2 FY25 Results Investor Briefing Invitation
LDX
lumos diagnostics holdings limited
Add to My Watchlist
2.90%
!
6.7¢

Ann: Q2 FY25 Results Investor Briefing Invitation, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.7¢ |
Change
-0.002(2.90%) |
Mkt cap ! $50.15M |
Open | High | Low | Value | Volume |
7.0¢ | 7.0¢ | 6.7¢ | $98.86K | 1.443M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 505996 | 6.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 183440 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6130 | 0.072 |
1 | 50000 | 0.068 |
6 | 855254 | 0.067 |
5 | 954212 | 0.066 |
6 | 1016815 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.068 | 20990 | 1 |
0.070 | 100000 | 1 |
0.071 | 271000 | 2 |
0.072 | 1136161 | 7 |
0.073 | 481718 | 4 |
Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |